Main

related bits

253

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-03-13 13:47:04

expired found date

-

created at

2024-06-03 10:50:34

updated at

2026-03-11 16:03:28

Domain name statistics

length

12

crc

11716

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

76566827

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

98123

mp size raw text

3130

mp inner links count

1

mp inner links status

20 (imported)

Open Graph

title

Anjarium Biosciences

description

Pioneering the next generation of non-viral gene therapy - by tackling more diseases, more precisely and in a more personalized way.

image

site name

Anjarium Biosciences

author

updated

2025-12-14 20:04:04

raw text

Anjarium Biosciences About Us Our Approach Investors Press Releases Careers About Us Our Approach Investors Press Releases Careers Scroll Accelerating access to revolutionary cell and gene therapies with next generation tools and technology platforms       About Us Anjarium Biosciences AG is a cell and gene therapy tools and technology company based in Switzerland and the U.S.  Anjarium is capable of designing, manufacturing and supplying synthetic DNA as well as targeted non-viral vectors for the delivery of a diverse set of payloads.  We are advancing two novel technology platforms both of which are poised to disrupt current best-in-class technologies enabling improved access to genetic medicines: pxDNA is our cell-free platform for manufacturing synthetic linear DNA.  Our scalable process stands ready to replace plasmid DNA as an alternative enabling transformative biotechnology solutions for genetic medicines....

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Koronawirus (17)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

2456

text words

415

text unique words

211

text lines

61

text sentences

12

text paragraphs

5

text words per sentence

34

text matched phrases

1

text matched dictionaries

2

RSS

rss path

rss status

3 (priority 3 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap path

sitemap status

1 (priority 1 already searched, no matches found)

sitemap review version

1

sitemap urls count

0

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

-

sitemap process date

-

sitemap first import date

-

sitemap last import date

-